Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06629610 · ClinicalTrials.gov registry record · NA

Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)

A NA study of Heart Disease, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
368
Enrollment target
2
Study locations

NCT06629610: Recruiting NA study of Heart Disease, sponsored by Oregon Health and Science University.

NCT06629610 is a NA study of Heart Disease that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 368 participants, below the 2,035-participant average among 31 other Heart Disease trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06629610, a NA study of Heart Disease, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
368 participants
Enrollment target
2
Study locations

Study Summary

Heart disease is the leading cause of death for Alaska Native men and the second leading cause of death (after cancer) among women and Alaska Native people overall. The overarching goal of the proposed multilevel, multicomponent intervention, Diet and Active Lifestyle - Yuuyaraq (DAiLY), is to reduce consumption of highly processed store-bought foods while promoting intake of subsistence foods, healthy store-bought foods, and a more active lifestyle to reduce heart disease risk. The Yup\'ik word Yuuyaraq means 'the Yup'ik way of life' and encompasses a worldview in which living in harmony with the environment, as well as sharing of subsistence foods and traditional knowledge is central. The proposed DAiLY intervention is grounded in the Yup'ik worldview and Indigenous Food Sovereignty, and supported by a foundation of trust resulting from 22 years of continuous Community Based Participatory Research on heart disease risk andprotective factors with Yup'ik communities. DAiLY is a direct response to the intervention research requests of community partners and input from Yup'ik Community Research Associates and a Yup'ik Community Planning Group during the formative research and community engagement process shaping this proposal. The proposed intervention, based on the Warnecke model of health disparities and social cognitive theory, includes three components: 1) home-based workshops, framed in the Yupik worldview, led by Community Research Associates to facilitate interactive discussions with community members about healthy market foods, as well as the health benefits of locally harvested traditional foods and increased physical activity; 2) local food store interventions to increase access to, and help build demand for, healthy food options; and 3) traditional community activities, including Yuraq (Yup'ik traditional dance), Native sports events, and berry festivals, that provide opportunities to increase physical activity. The three components will be supp

Primary Outcome

Determine the effectiveness of the DAiLY intervention on heart disease risk by measuring: (1) change in a continuous metabolic syndrome risk score (primary outcome) in Yup\'ik adults at least 18 years old. The continuous metabolic syndrome score includes the weighted contributions of waist circumference, triglycerides, high density lipoprotein, glucose and blood pressure. The continuous metabolic syndrome score is a metabolic syndrome-severity Z score that adds predictive utility for future

Conditions Studied

Interventions

  • BEHAVIORAL DAiLY

Study Locations (2)

Alaska

  • Yukon-Kuskokwim Health Corporation - Bethel

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2024-10-18
Est. Completion 2029-04-30
Phase NA

What NCT06629610 shows while recruiting

NCT06629610 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, below the 2,035-participant average among 31 other Heart Disease trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which DAiLY is the first listed.

NCT06629610 reports a single indexed study location in Alaska, Oregon.

Frequently Asked Questions

What is clinical trial NCT06629610 about?

NCT06629610 is a clinical study titled "Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)". Heart disease is the leading cause of death for Alaska Native men and the second leading cause of death (after cancer) among women and Alaska Native people overall. The overarching goal of the proposed multilevel, multicomponent intervention, Diet and Active Lifestyle - Yuuyaraq (DAiLY), is to reduc...

What is the current status of trial NCT06629610?

This trial is currently recruiting. It is a NA study. The enrollment target is 368 participants. The study started on 2024-10-18. Estimated completion is 2029-04-30.

What conditions does trial NCT06629610 study?

This clinical trial studies the following conditions: Heart Disease.

What interventions are being tested in trial NCT06629610?

The interventions under investigation include: DAiLY (BEHAVIORAL).

Who is sponsoring clinical trial NCT06629610?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06629610 being conducted?

This trial has 2 study locations across Alaska, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06629610's enrollment target sits among peer trials

368 10th of 31 higher than 22 of 31 other Heart Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04675476 · 368 participants · NA

    A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

  • NCT05215353 · 368 participants · Phase 4

    A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

  • NCT06182397 · 368 participants · NA

    Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

  • NCT06114836 · 369 participants · NA

    GERD Infant Feeding Therapeutics Trial (GIFT Trial)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06629610, the US trial registry maintained by the National Library of Medicine. NCT06629610 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.